Miguel Torralba-González

22PUBLICATIONS
102CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsAboriginal and Torres Strait Islander medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 25, 2026
Cumulative Metformin Use and Hepatocellular Carcinoma Risk After HCV SVR: A Multicentre Cohort Study.

|Jul 16, 2026
Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

|Apr 21, 2026
Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.

|Mar 26, 2026
Use of long-acting cabotegravir and rilpivirine in people living with HIV: A prospective observational cohort study.

Ana Codonal, Alicia Lázaro, Elena Martínez

|Feb 18, 2026
Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapy.

Jose-Ramon Blanco, Miguel Torralba, María Saumoy

|Dec 08, 2025
Critical Appraisal Tools for Evaluating Artificial Intelligence in Clinical Studies: Scoping Review.

Juan B Cabello, Vicente Ruiz Garcia, Miguel Torralba

Pageof 4

Frequent Collaborators

5 joint publications

Pablo Martínez-Blanco

4 joint publications

Carmen Hidalgo-Tenorio

4 joint publications

Alfonso Cabello-Úbeda

4 joint publications

Jesús Troya García